130 related articles for article (PubMed ID: 3466871)
1. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1986 Feb; 53(2):189-95. PubMed ID: 3513813
[TBL] [Abstract][Full Text] [Related]
4. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
Makovitzky J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
[TBL] [Abstract][Full Text] [Related]
5. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on the expression of gastrointestinal-cancer-associated antigen, PA8-15, CA19-9 and the blood-group antigens in non-malignant and malignant human pancreatic tissues.
Egami H; Sakamoto K; Yoshimura R; Arai M; Takiyama Y; Pour PM
J Cancer Res Clin Oncol; 1990; 116(4):365-71. PubMed ID: 2391357
[TBL] [Abstract][Full Text] [Related]
7. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
[TBL] [Abstract][Full Text] [Related]
8. Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1991 Mar; 63(3):386-9. PubMed ID: 1848439
[TBL] [Abstract][Full Text] [Related]
9. Expression of Tn, sialosyl Tn, and T antigens in human pancreas.
Itzkowitz S; Kjeldsen T; Friera A; Hakomori S; Yang US; Kim YS
Gastroenterology; 1991 Jun; 100(6):1691-700. PubMed ID: 1850375
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Int J Pancreatol; 1987; 2(5-6):349-60. PubMed ID: 3320227
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
Blind PJ; Dahlgren ST
Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
[TBL] [Abstract][Full Text] [Related]
12. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of human gastrointestinal cancer-associated antigen detected by monoclonal antibody PA 8-15.
Yoshimura R; Sakamoto K; Egami H; Akagi M
Jpn J Cancer Res; 1988 Feb; 79(2):255-63. PubMed ID: 3130361
[TBL] [Abstract][Full Text] [Related]
14. Blood-group antigen expression during pancreatic cancer induction in hamsters.
Pour PM; Uchida E; Burnett DA; Steplewski Z
Int J Pancreatol; 1986 Dec; 1(5-6):327-40. PubMed ID: 3316427
[TBL] [Abstract][Full Text] [Related]
15. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis.
Malesci A; Tommasini MA; Bonato C; Bocchia P; Bersani M; Zerbi A; Beretta E; Di Carlo V
Gastroenterology; 1987 Jan; 92(1):60-7. PubMed ID: 3465666
[TBL] [Abstract][Full Text] [Related]
16. Isolation and immunohistochemical characterization of a pancreatic carcinoma-associated monoclonal antibody.
Halwani F; Cheung M; Jothy S
Exp Mol Pathol; 1990 Oct; 53(2):99-111. PubMed ID: 1702063
[TBL] [Abstract][Full Text] [Related]
17. [Importance of the tumor-associated antigen CA 19-9 in the differential diagnosis of pancreatic diseases].
Heptner G; Domschke S; Schneider MU; Domschke W
Dtsch Med Wochenschr; 1985 Apr; 110(16):624-8. PubMed ID: 3857159
[TBL] [Abstract][Full Text] [Related]
18. Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9.
Haglund C; Kuusela P; Jalanko H; Roberts PJ
Int J Cancer; 1987 Apr; 39(4):477-81. PubMed ID: 3470260
[TBL] [Abstract][Full Text] [Related]
19. Expression of oncofoetal pancreatic antigens in hamster adult pancreas during experimental carcinogenesis.
Escribano MJ; Carré-Llopis A; Loridon-Rosa B
Br J Cancer; 1985 Feb; 51(2):187-93. PubMed ID: 3881120
[TBL] [Abstract][Full Text] [Related]
20. Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor.
Tatsuta M; Yamamura H; Iishi H; Ichii M; Noguchi S; Yamamoto R; Okuda S
Cancer; 1985 Dec; 56(11):2669-73. PubMed ID: 3863691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
